aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
GlySens, Inc., based in San Diego, develops and manufactures implantable continuous glucose monitoring systems aimed at improving diabetes care. Their primary market includes endocrinologists and diabetes centers across the United States, focusing on providing advanced solutions for blood glucose monitoring.
GlySens has made significant strides in diabetes management with their innovative implantable sensors. Their technology offers continuous, long-term glucose monitoring, enhancing patient care and treatment outcomes. Their impact is notable in the medical community, contributing to better diabetes management practices.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Glucose Monitors
Technology
Medical Devices
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
United States
When was Glysens founded?
Glysens was founded in 1998.
Where is Glysens’s headquarters located?
Glysens’s headquarters is located in San Diego, CA, US.
When was Glysens’s last funding round?
Glysens’s most recent funding round was for $20M (USD) in January 2016.
How many employees does Glysens have?
Glysens has 75 employees as of Feb 5, 2024.
How much has Glysens raised to-date?
As of July 05, 2023, Glysens has raised a total of $34M (USD) since Jan 4, 2016.
Add Comparison
Total Raised to Date
$34M
USD
Last Update Jan 4, 2016
Last Deal Details
$20M
USD
Jan 4, 2016
Series D
Total Employees Over Time
75
As of Feb 2024
Glysens Address
6450 Lusk Boulevard
suite e-109
San Diego,
California
92121
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts